F. Corapçioglu And N. Sarper, "Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.," Pediatric hematology and oncology , vol.22, pp.59-70, 2005
Corapçioglu, F. And Sarper, N. 2005. Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.. Pediatric hematology and oncology , vol.22 , 59-70.
Corapçioglu, F., & Sarper, N., (2005). Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.. Pediatric hematology and oncology , vol.22, 59-70.
Corapçioglu, F, And NAZAN SARPER. "Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.," Pediatric hematology and oncology , vol.22, 59-70, 2005
Corapçioglu, F And Sarper, NAZAN. "Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.." Pediatric hematology and oncology , vol.22, pp.59-70, 2005
Corapçioglu, F. And Sarper, N. (2005) . "Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.." Pediatric hematology and oncology , vol.22, pp.59-70.
@article{article, author={F Corapçioglu And author={NAZAN SARPER}, title={Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.}, journal={Pediatric hematology and oncology}, year=2005, pages={59-70} }